Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation
- PMID: 12792380
- DOI: 10.1097/01.inf.0000066242.21072.9d
Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation
Abstract
Background: Children <2 years old have been targeted for routine pneumococcal conjugate vaccine. Laboratory-confirmed illnesses represent a minority of all medical care utilization for pneumococcal disease.
Objectives: To evaluate trends in medical care utilization for Streptococcus pneumoniae-related illnesses before introduction of pneumococcal conjugate vaccine (1995 to 1999) and to evaluate regional variation in utilization.
Method: Retrospective cohort analysis with the use of computerized billing data of children <2 years old enrolled in Tennessee (Medicaid program) and the Rochester, NY area (commercial and Medicaid managed care plans). Secular trends (1995 to 1999) analysis included 316 519 person-years in Tennessee Medicaid. Regional variation (1998 to 1999) analysis included 130 525 person-years in Tennessee and 26 140 and 3184 person-years in commercial and Medicaid plans, respectively, in the Rochester, NY area.
Results: From 1995 to 1999 in Tennessee, the net increase in medical care visits was 12% for pneumococcal and nonspecific pneumonia and invasive disease, 11% for otitis media and 11% for other acute respiratory conditions. Analysis of trends indicated that a significant vaccine effect could be detected if utilization rates declined by 32, 9 and 21%, respectively. In the Tennessee Medicaid population, rates of pneumococcal and nonspecific pneumonia and invasive disease were 60% higher than in either the New York Medicaid or the commercial populations. Children with commercial insurance had the highest medical care utilization for otitis media.
Conclusions: Geographic variation and large population differences in medical care utilization among children < 2 years old in three study populations suggest that the benefits of vaccination may vary by region and by population. In the Tennessee Medicaid population, temporal trends and year-to-year variability of pneumococcal-related outcomes were observed from 1995 to 1999. In this population a 10% decline in otitis media visits after the introduction of pneumococcal conjugate vaccine could be detected by trend analysis.
Similar articles
-
Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine.Pediatrics. 2007 Apr;119(4):707-15. doi: 10.1542/peds.2006-2138. Pediatrics. 2007. PMID: 17403841
-
Population-based impact of pneumococcal conjugate vaccine in young children.Pediatrics. 2004 Sep;114(3):755-61. doi: 10.1542/peds.2003-0592-F. Pediatrics. 2004. PMID: 15342850
-
Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.Pediatrics. 2008 Feb;121(2):253-60. doi: 10.1542/peds.2007-0619. Pediatrics. 2008. PMID: 18245415
-
The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.Infect Dis Clin North Am. 2005 Sep;19(3):629-45. doi: 10.1016/j.idc.2005.05.008. Infect Dis Clin North Am. 2005. PMID: 16102653 Review.
-
Pneumococcal resistance in perspective: how well are we combating it?Pediatr Infect Dis J. 2004 Feb;23(2 Suppl):S125-8. doi: 10.1097/01.inf.0000112526.55182.e0. Pediatr Infect Dis J. 2004. PMID: 14770075 Review.
Cited by
-
Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.Respir Res. 2007 Feb 21;8(1):12. doi: 10.1186/1465-9921-8-12. Respir Res. 2007. PMID: 17313667 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical